Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026)

Jushi Holdings (JUSHF) reported Cash from Investing Activities of -$4.1 million for Q1 2026, up 6.74% year-over-year from -$3.8 million in Q1 2025, and down 32.9% quarter-over-quarter from -$3.1 million in Q4 2025.

Jushi Holdings (JUSHF) Cash from Investing Activities (2021 - 2026) Analysis & Trends

Jushi Holdings (JUSHF) has 6 years of Cash from Investing Activities data on file, last reported at -$4.1 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$4.1 million, up 6.74% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.9 million (down 20.82% YoY), and the FY2025 annual result was -$13.2 million, down 87.09% from the prior year.
  • Cash from Investing Activities retreated to -$4.1 million in Q1 2026 per JUSHF's latest filing, from -$3.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $1.7 million in Q2 2024 and troughed at -$38.1 million in Q2 2022.
  • A 5-year average of -$6.6 million and a median of -$4.1 million in 2026 frame the typical range for Cash from Investing Activities.
  • On a YoY basis, Cash from Investing Activities climbed as much as 348.1% in 2024 and fell as far as 2112.2% in 2024.
  • A 5-year view of Cash from Investing Activities shows it stood at -$7.7 million in 2022, then jumped by 95.76% to -$328000.0 in 2023, then tumbled by 2112.2% to -$7.3 million in 2024, then surged by 57.69% to -$3.1 million in 2025, then slumped by 32.9% to -$4.1 million in 2026.
  • Business Quant data shows JUSHF's Cash from Investing Activities at -$4.1 million in Q1 2026, -$3.1 million in Q4 2025, and -$5.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 Jushi Holdings - - 29.88 Mn -4.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.08 Mn
Mar 31, 2026 -4.08 Mn
Dec 31, 2025 -3.07 Mn
Dec 31, 2025 -3.07 Mn
Sep 30, 2025 -5.32 Mn
Sep 30, 2025 -5.32 Mn
Jun 30, 2025 -459,000.00
Jun 30, 2025 -459,000.00
Mar 31, 2025 -4.38 Mn
Mar 31, 2025 -4.38 Mn
Dec 31, 2024 -7.26 Mn
Dec 31, 2024 -7.26 Mn
Sep 30, 2024 -770,000.00
Sep 30, 2024 -770,000.00
Jun 30, 2024 1.70 Mn
Jun 30, 2024 1.70 Mn
Mar 31, 2024 -743,000.00
Mar 31, 2024 -743,000.00
Dec 31, 2023 -328,000.00
Dec 31, 2023 -328,000.00